What is the expected life span and quality of life for a patient diagnosed with essential thrombocythemia (ET)? In this Ask the Expert segment, Dr. Prithviraj Bose from The University of Texas MD Anderson Cancer Center discusses reviews the typical monitoring and risks of ET and refers to the diagnosis as the most favorable prognosis among the classic MPN diagnoses.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo